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Numerical evaluation of microwave thermal ablation to treat
small adrenocortical masses
G. Ruvio (1, 2), J. Eaton-Evans (1), A. Shahzad (1), M. O’Halloran (1, 3)

(1) College of Engineering and Informatics, National University of Ireland Galway, Ireland.
(2) Antenna & High Frequency Research Centre, Dublin Institute of Technology, Ireland.
(3) School of Medicine, National University of Ireland Galway, Ireland.

Abstract: In this paper microwave thermal ablation is numerically evaluated in the context of a
treatment for Conn’s Syndrome. This condition is caused by a benign shallow tumour in the cortex
of adrenal gland. The modelling and design of microwave applicator to deliver thermal ablation to
the adrenal gland requires accurate tissue characterisation. Measuring the dielectric properties of the
constituent tissues in the adrenal gland, i.e. cortex and medulla, enables more accurate numerical
modelling for electromagnetic and thermal simulations. This study presents an anatomically and
dielectrically realistic numerical model of the adrenal gland, and investigates the feasibility of
applying controlled heating to small targets in the adrenal cortex. In addition, the use of dielectric
contrast between the fat and the cortex of the adrenal gland to focus the thermal energy in the gland
has also been studied. Being conscious of limitations of numerical simulation of complex multiphysics problems like the microwave ablative treatment, calculated results provide a preliminary
description of the electromagnetic and thermal phenomena involved.

1. INTRODUCTION

High blood pressure, also known as hypertension, is a global health problem that accounts for more
than 9.4 million deaths every year, and affects over 1 billion people worldwide [1]. Hypertension
directly causes approximately 25% of heart attacks in Europe and, in its progressed form of
cardiovascular disease, is responsible for 42% of all deaths across Europe annually. One of the most
common curable cause of secondary hypertension is Primary Aldosteronism (PA, also known as
Conn’s Syndrome) [2, 3]. PA is thought to account for up to 18% of all cases of hypertension
within the hypertensive population [3, 4]. It is caused by benign, shallow, hormone-eluding
adenomas on the cortex of the adrenal gland. A simplified anatomical model of the adrenal gland is
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shown in Fig. 1. Adrenal adenomas can vary in size considerably, but are typically less than 1 cm in
diameter, and are usually identified incidentally during radiologic examinations [5].

Figure 1: Constituent tissues of the adrenal gland.

PA and associated hypertension can be cured by eliminating these adenomas, however existing
treatment options are limited. Currently the most commonly performed treatment for PA is an
adrenalectomy, which involves the complete removal of the diseased adrenal gland [3, 6, 7]. This
approach has been shown to be effective in treatment of PA where it is confined to one gland [7],
with biochemical levels and blood pressure returning to normal [6]. However, PA often reoccurs in
the remaining contralateral adrenal gland. In such cases the disease must be managed medically, but
available drug treatments are poorly tolerated by patients due to their significant side-effects [7].
These challenges provide a clear motivation for a less invasive treatment that can be used to
precisely target the hormone-eluding adenomas in the adrenal gland. It should spare healthy tissue
to ensure that the function of the gland is preserved, and eliminate the requirement for surgical
resection.

Thermal ablation is accepted as a safe and effective alternative to surgical resection for elimination
of lesions in a range of organs including the liver, kidneys and lungs [8]. Early thermal ablation
systems used Radio Frequency Ablation (RFA), and were designed primarily for ablation of liver
tumours. However, RFA systems have also been used in other clinical applications, such as kidney,
lung, bone, and adrenal glands [9, 10, 11]. RFA produces resistive heating by applying electric
current in the targeted lesion. The heat is dissipated into the surrounding tissue by thermal
2

conduction. This makes it susceptible to heat sinks or changes to tissue impedance which can result
in an undesirable elliptical or non-uniform ablation zone [9].

The emergence of Microwave Ablation (MWA) has addressed some of the problems in RFA,
providing a means to achieve a faster and more controlled ablation and with less critical dose of
anaesthetics [11, 12, 13]. This makes MWA well suited for treatment of lesions in the adrenal gland
where a precise ablation zone is required to spare healthy tissue [14].

The rate of heating during MWA is a function of the dielectric properties of the target tissue, which
are a function of the water content of the target tissue [12]. The adrenal gland is composed of three
principal tissue layers: an outer fatty capsule, the cortex where the hormone-eluding adenomas are
located, and the medulla (see Figure 1). Each tissue type in the adrenal gland has different dielectric
properties which will affect the rate of heating and the characteristics of the ablation zone.
Therefore, the knowledge of accurate dielectric properties and anatomy of the gland is critical in
designing a MWA system for treatment of adrenal tumours.

This paper presents an anatomically realistic and dielectrically accurate numerical model of the
adrenal gland for MWA at 2.45 GHz. The effect of gland structure, ablation power, and therapy
duration on the ablation zone is investigated through numerical simulations performed by using the
3-D Computer Simulation Technology Microwave Studio (CST MWS Suite 2017, Darmstadt,
Germany). In addition, the feasibility of using the differential in tissue properties to control the
ablation zone is investigated. To the best of our knowledge, this is the first numerical evaluation of
the microwave ablation in the adrenal gland that models the dielectric properties of fat, cortex and
medulla components.

The remainder of this paper is organized as follows: Section 2 describes the numerical model and
details the dielectric and thermal properties of the tissues. The multi-physics electromagnetic
thermal ablative problem is discussed in Section 3 and conclusions are presented in Section 4.
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2. NUMERICAL MODELLING
The adrenal gland represents a complex scenario to model, both in terms of tissue heterogeneity and
morphology. Figure 2 shows an anatomical model of a typical adrenal gland site in adult human
based on the data in [15].

Figure 2: Anatomical model of a typical adrenal gland in adult human

The adrenal gland sits on top of the kidney and it is surrounded by an infiltrated fat capsule. The fat
tissue is then covered in a thin film of connective tissue. Accurate modelling of the adrenal site for
electromagnetic/thermal multi-physics simulations requires a realistic characterization of each
tissue in terms of dielectric and thermal properties at the target frequency and temperature operating
range.

A recent study on the dielectric properties of the adrenal gland reported anatomically realistic
dielectric model of the gland across the frequency range 0.5 – 20 GHZ [15]. This study overcomes
the issues with incorrect modelling of tissue in most of the recent literature [17, 18] where a
homogeneous dielectric model was introduced for the adrenal gland. In [16] a slim-form dielectric
probe (Keysight 85070E, Santa Rosa, CA, USA) was used for measurements in conjunction with a
vector network analyser (Keysight E8362B) to record the reflection coefficient (S11) at 101 linearly
spaced discrete frequency points over 0.5 to 20 GHz. The S11 parameters were converted to
complex permittivity using Keysight material measurement software suite (Keysight N1500A).
4

Dielectric properties are generally expressed in the form of a parametric model. Cole-Cole model is
commonly used to represent the frequency dependent permittivity of biological tissues. In the ColeCole mode, the frequency dependent complex permittivity is represented as:
 = ஶ + 
ே

ୀଵ

∆
௦
+
ଵିఈ
1 +    

(1)

where ε∞ is the permittivity at highest frequency; ∆εn is the magnitude of nth relaxation; ω is the
angular frequency in radians per second; τn is the relaxation time of the nth relaxation; αn is an
empirical parameter that accounts for broadening of the nth relaxation; σs is the static conductivity;
and ε0 is absolute permittivity. The measured dielectric properties were fitted to the two-pole ColeCole models for the cortex and medulla tissues of bovine adrenal gland described by the parameters
in Table I.

TABLE I
Parameters of the two pole Cole-Cole model of bovine adrenal tissues [16]
Parameter

Adrenal Cortex

Adrenal Medulla

ε∞

3.57

3.88

∆ε1

47.08

52.95

τ1

8.33 ps

7.01 ps

α1

0.16

0.17

∆ε2

52.31

62.05

τ2

1.69 ns

4.28 ns

α2

0.03

0.14

σs

0.46

0.62

The sets of dielectric properties shown in Table I are slightly different, with the medulla being
electromagnetically denser than the cortex. This contrast suggests that the microwave radiation will
travel more rapidly in the cortex than in the medulla. In ablative treatments with short durations
(less than a minute) direct heating due to microwave radiation will dominate conductive heating.
Therefore, an improved dielectric characterisation of the targeted tissues allows more realistic
numerical simulation of the temperature profiles [12].

The adrenal gland rests on the top portion of the kidney (see Figure 1). The lower surface of the
adrenal gland is in direct contact with the kidney cortex tissue and its remaining free surfaces
surrounded by fat. Figure 3 provides dielectric properties for the kidney cortex and fat tissue
5

component in terms of permittivity and electric conductivity as reported in [19]. The thermal
properties of the tissues are shown in Table II.
The numerical model generated for the multi-physics simulations discussed below does not include
blood perfusion as this aspect is considered secondary for the size of the targeted region and the
duration of the ablative treatment. Open boundary conditions were adopted to solve both the
electromagnetic and thermal problems. Finally, the multilayer structure of the model was adaptively
meshed to be denser in regions with higher permittivity. The size of meshing tetrahedrons spans
between minimum and maximum edge lengths of 0.019 mm and 0.99 mm, respectively.

It is proposed to position the ablation needle (applicator) at the interface between the fat and adrenal
cortex layers, where the fat layer will act as an insulator due to significantly lower dielectric and
thermal conductivity properties than the surrounding tissue. This placement of the needle should
result in an ablation zone that primarily targets the cortex where hormone-eluding adenomas are
located. The fat / cortex interface appears distinctly clear in CT imaging [20] and may provide a
practical approach for targeting the cortex whilst sparing the medulla and preserving gland function.

Figure 3: Permittivity and Electric conductivity of tissues adjacent to the adrenal site [19]

TABLE II
6

Thermal properties of tissues in the adrenal site [19]
Thermal conductivity

Tissue

Heat capacity [Kj/Kg/°C]

Adrenal medulla

3.745

0.54

Adrenal cortex

3.587

0.53

Infiltrated fat

2.348

0.21

Kidney cortex

3.763

0.53

[W/m/°C]

A numerical multilayer planar model was developed to validate this approach. It also sought to
identify treatment durations and power settings where the ablation was confined by the fat layer to
the cortex and did not reach the medulla. The ablation antenna was positioned parallel to the
interface between the fat and the adrenal cortex layer in a simplified, planar geometry shown in
Figure 4. The cortex and medulla were represented by two 5 mm thick layers corresponding a
typical human adrenal gland structure. The fat capsule was modelled by a 15 mm thick layer, which
is larger than that seen in vivo, but provided a simple and robust boundary condition for the
preliminary analysis. The ablation antenna used in this paper is a 17 gauge omni-directional
monopole applicator. The antenna is a coaxial monopole which is obtained by exposing a 6-mm
length of the inner conductor of the feed cable when this is immerged in the water of the cooling
system. The applicator presents an S11 performance better than -12 dB in all working conditions
under investigation. While more complex antenna solutions such as slot and directive antennas were
explored, a simple coaxial monopole was adopted in this preliminary study to stress the attention on
the complex multi-tissue model here proposed.
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Figure 4: Planar multilayer model of the adrenal site

The planar model formed the basis for a more complex three dimensional (3D) simulation that
included an anatomically realistic geometry. Figure 5 details the gland structure intended to
represent a typical human adrenal. It was situated with the lower surfaces contacting the kidney
cortex and the remainder surrounded by the fat capsule. The thickness of the adrenal cortex ranged
from approximately 5 to 10 mm. The ablation needle was positioned at the interface between the
cortex and fat layer where the cortex is thinner as shown in Figure 5. The background medium in
the model was set as blood to provide a stable boundary condition. The target ablation temperature
was 60° C in all cases under investigation.

(a)

(b)

Figure 5: 3D multilayer model of the adrenal site and section view of the gland with needle
inserted: (a) 3D view; (b) cross-section.
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3. RESULTS

This section details the results of the planar and 3D simulations. Three power levels (i.e. 30, 60 and
90 W delivered at the distal tip) and three treatment durations (i.e. 15, 30 and 45 s) were considered.

Figure 6 displays the thermal distribution for each power and duration setting obtained from the
planar model. As expected, limited interaction with the adipose layer was observed compared to the
heat generated in the targeted cortex region at each power and time duration setting. The results also
indicate that the ablation zone is confined to the cortex in the ablations at low duration (30 s), even
with high power. Direct heating will dominate at treatment with low durations, when there is
limited time for conductive heating.

15 s

30 s

45 s

Colour ramp

30 W

60 W

90W

Figure 6: Ablation zone in planar multilayer model of the adrenal site for different power and
time settings.
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Similar shielding effects by the fat capsule were observed in the results obtained from the
simulation on the 3D geometry. The fat layer functioned to confine heating to the cortex at short
treatment durations and low/medium input powers (see Figure 7). At all settings, the ablation zone
is focussed towards the adrenal cortex and medulla; however at higher power and durations it
extended beyond the thin fatty capsule, posing a risk of damage to surrounding structures (e.g.
blood vessels, nerves, connective tissue, etc.). This demonstrates that the thickness and integrity of
the fat capsule as well as accurate placement of the ablation probe is critical to maximising the
shielding effect.
Analysis of the results shown in Figure 6 also indicate insufficient heating (< 60 oC) for tissue
ablation occurred at 30 W input power, even at the high duration (45 s). Longer durations were not
considered because they would favour conductive heating which does not differentiate between the
tissue types as effectively as direct heating. The results of this analysis suggest that the optimum
treatment may use a high power (e.g. 60 or 90 W) for a short duration to maximise direct heating of
the cortex whilst sparing the medulla.
The 3D model also provided a more realistic representation of the needle placement. Its location is
complicated by the curvature of this fat / cortex interface. This resulted in discrepancies between
the characteristics of the ablation zones observed from the planar model shown in Figure 6 where
the needle was perfectly aligned to the fat/cortex interface. The heat maps of the 3D simulations are
shown in Figure 7. In the 3D model the antenna is fully embedded into the fat tissue, which resulted
in attenuation. This further highlights the importance of accurate probe placement to successfully
target the cortex whilst sparing the surrounding tissues.
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15 s

30 s

45 s

Colour map

30 W

60 W

90W

Figure 7: Ablation zone in 3D multilayer model of the adrenal site for different power/time
settings.
The numerical analysis presented in the paper sought to carry out a realistic simulation of
microwave ablation in the adrenal gland. However, the following limitations to the scope of the
analysis are noted. Only one needle location and orientation was considered. Moreover, the
properties of the hormone-eluding adenomas were not modelled as not yet fully characterized.

4. CONCLUSIONS

A multiphysics simulation of MWA in the adrenal gland including constituent tissues was
presented. Planar and 3D models were used to analysis the effects of MW thermal ablation at 2.45
GHz, performed with a 17 gauge omni-directional needle. It was demonstrated that placement of
11

the needle at the interface between the cortex and fat capsule results in an ablation zone which
targets the cortex. Furthermore, the use of high power with a short duration can maximise the direct
heating in the targeted cortex of the gland. The results generated by this analysis suggest that
treatments with a power of 60 or 90 W for 15 s result in ablation of a 5-mm thick adrenal cortex
region while sparing surrounding medulla.
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